Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2025)
Cresco Labs (CRLBF) has disclosed Non-Current Deferred Tax Liability for 5 consecutive years, with $89.4 million as the latest value for Q4 2023.
- For the quarter ending Q4 2023, Non-Current Deferred Tax Liability rose 18.99% year-over-year to $89.4 million, compared with a TTM value of $89.4 million through Dec 2023, up 18.99%, and an annual FY2023 reading of $89.4 million, up 18.99% over the prior year.
- Non-Current Deferred Tax Liability was $89.4 million for Q4 2023 at Cresco Labs, up from $75.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $89.4 million in Q4 2023 and bottomed at $23.2 million in Q4 2019.
- Average Non-Current Deferred Tax Liability over 5 years is $62.9 million, with a median of $75.1 million recorded in 2022.
- The sharpest move saw Non-Current Deferred Tax Liability skyrocketed 107.92% in 2021, then decreased 12.29% in 2022.
- Year by year, Non-Current Deferred Tax Liability stood at $23.2 million in 2019, then skyrocketed by 77.5% to $41.2 million in 2020, then surged by 107.92% to $85.7 million in 2021, then decreased by 12.29% to $75.1 million in 2022, then grew by 18.99% to $89.4 million in 2023.
- Business Quant data shows Non-Current Deferred Tax Liability for CRLBF at $89.4 million in Q4 2023, $75.1 million in Q4 2022, and $85.7 million in Q4 2021.